Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1412, 2003-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Higher thrombocytopenia risk with abciximab than with tirofiban
Inpharma, Vol. 1, Iss. 1444, 2004-01 ,pp. :
Access to resources
Recommend
Stenting worth it, but value of abciximab uncertain
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 443, 2003-01 ,pp. :
Stenting worth it, but value of abciximab uncertain
Inpharma, Vol. 1, Iss. 1418, 2003-01 ,pp. :
By Kintscher U. Kappert K. Schmidt G. Doerr G. Grill M. Wollert-Wulf B. Graefe M. Fleck E. Graf K.
European Journal of Pharmacology, Vol. 390, Iss. 1, 2000-02 ,pp. :
Risperidone to olanzapine switch worth it in schizophrenia
Inpharma, Vol. 1, Iss. 1426, 2004-01 ,pp. :